Concurrent 1B: HCV Trends: Are we on Track for Elimination Targets?
Tracks
​
Wednesday, October 9, 2024 |
1:45 PM - 3:15 PM |
Nikos Skalkotas Hall |
Speaker
Dr Norah Palmateer
Reader
GCU
MAJOR REDUCTION IN THE POPULATION PREVALENCE OF CHRONIC HEPATITIS C VIRUS (HCV) AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN SCOTLAND: EVIDENCE ON HCV ELIMINATION TARGETS
1:45 PM - 2:00 PMBiography
Norah Palmateer is a Reader in Public Health at Glasgow Caledonian University and holds an honorary appointment with Public Health Scotland. Her research relates primarily to the epidemiology and prevention of blood-borne viruses and other infections associated with injecting drug use.
Mr Jaskaran Cheema
Phd Student
University Of California San Diego
Modeling Hepatitis C Virus Elimination in the United States: Are we on track to reach incidence targets?
2:00 PM - 2:15 PMBiography
I am a first-year epidemiology student in the joint doctoral program at UC San Diego and San Diego State University. My research interests include infectious disease and health economic modeling.
Dr Joanne Carson
Infectious disease and data scientist
Kirby Institute, UNSW
DEVELOPMENT OF AI-AUGMENTED HCV SURVEILLANCE FOR AUSTRALIA
2:15 PM - 2:30 PMBiography
Dr Joanne Carson is cross-disciplinary infectious disease and data science researcher interested in precision medicine, big data analytics, machine learning and artificial intelligence (AI).
Mr Shane Tillakeratne
Phd Student / Ra
Unsw/ Kirby Institute
Hepatitis C mortality trends in the era of viral hepatitis elimination in New South Wales, Australia
2:30 PM - 2:45 PMBiography
Shane is a PhD candidate at the Kirby Institute, examining viral hepatitis elimination strategies and treatment outcomes through analysis of population-level data. His research aims to monitor progress towards viral hepatitis elimination, particularly among marginalised communities in Australia. Shane is particularly interested in identifying underserved populations to accelerate elimination efforts.
Dr Olga Anagnostou
MD, Organisation Against Drugs
Organisation Against Drugs (OKANA)
Professor Carla Treloar
Professor
UNSW Sydney
The role of health systems in Hepatitis C point-of-care testing in Australia: a qualitative study with policymakers
2:50 PM - 2:55 PMBiography
Carla Treloar is Scientia Professor at the Centre for Social Research in Health at UNSW, Sydney Australia. Carla has published more than 300 peer-reviewed papers. She is co Editor in Chief of the International Journal of Drug Policy and served as senior editor for qualitative research for Addiction from 2018-2024.
Dr Dimitris Basoulis
Attending Physician
Laiko General Hospital
Dr Aaron Lim
Lecturer in Infectious Disease Mathematical Modelling
University of Bristol
Prevalence, Trends, and Distribution of Hepatitis C Virus among the General Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis
3:00 PM - 3:05 PMBiography
I am an infectious disease mathematical modeller interested in global health, especially in low- and middle-income countries. My recent modelling work has focussed on developing dynamic transmission models to evaluate the impact and cost-effectiveness of interventions for HCV and HIV epidemics in the general population and people who inject drugs.
INHSU 2024
Q&A
3:05 PM - 3:15 PMBiography
Chairperson
Zoë Greenwald
PhD Candidate
University Of Toronto
Peter Vickerman
Professor Of Infectious Disease Modelling
University of Bristol
